Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02302495
What this trial is testing

Study of Carfilzomib Weekly Plus Melphalan and Prednisone in Untreated Symptomatic Elderly Multiple Myeloma

Who this might be right for
Multiple Myeloma
University Hospital, Lille 32
Testing effectiveness (Phase 2)Study completedNCT00045136
What this trial is testing

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Poniard Pharmaceuticals
Not applicableStudy completedNCT03320044
What this trial is testing

Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing

Who this might be right for
CarcinomaNon-small-cell Lung CancerLung Neoplasm
Peking University People's Hospital 100
Not applicableStudy completedNCT05739110
What this trial is testing

HCC Staging Modified by Tumor Micronecrosis

Who this might be right for
Hepatocellular Carcinoma
Zhejiang University 1,100
Testing effectiveness (Phase 2)Study completedNCT01580410
What this trial is testing

Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix

Who this might be right for
Carcinoma of the AppendixPrimary Peritoneal Cavity Cancer
Wake Forest University Health Sciences 136
Testing effectiveness (Phase 2)Ended earlyNCT01625260
What this trial is testing

ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Altor BioScience 12
Early research (Phase 1)Ended earlyNCT04318327
What this trial is testing

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 96
Not applicableActive Not RecruitingNCT04813042
What this trial is testing

Determining the Effectiveness of Working Out Dads to Reduce Mental Health Difficulties in Fathers of Young Children

Who this might be right for
Mental Health Issue
Murdoch Childrens Research Institute 293
Testing effectiveness (Phase 2)Looking for participantsNCT06168786
What this trial is testing

Cadonilimab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With MSS CRC

Who this might be right for
Colorectal Cancer
Huazhong University of Science and Technology 40
Large-scale testing (Phase 3)Looking for participantsNCT04969731
What this trial is testing

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
GC Cell Corporation 408
Large-scale testing (Phase 3)Study completedNCT00008229
What this trial is testing

Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT03808272
What this trial is testing

AXIOS CHINA (E7148)

Who this might be right for
Pancreatic Pseudocyst and Walled-off Necrosis
Boston Scientific Corporation 31
Testing effectiveness (Phase 2)Looking for participantsNCT07473167
What this trial is testing

Study of Safety and Efficacy of TC011 in the Relapsed/Refractory Large B Cell Non-Hodgkin Lymphoma Patients

Who this might be right for
Relapsed Large B-cell LymphomaRefractory Large B-cell LymphomaDiffuse Large B-cell Lymphoma (DLBCL)+3 more
TICAROS Co., Ltd. 98
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Not applicableStudy completedNCT05181800
What this trial is testing

FIRMAGON® Intensive Drug Monitoring

Who this might be right for
Prostate Cancer
Ferring Pharmaceuticals 1,454
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07594028
What this trial is testing

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

Who this might be right for
Advanced Malignant Solid Tumor
Sinocelltech Ltd. 126
Not applicableUnknownNCT05983172
What this trial is testing

Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,500
Not applicableWithdrawnNCT03633539
What this trial is testing

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Who this might be right for
Colorectal CancerColonic NeoplasmsRectal Neoplasms+4 more
Ruijin Hospital
Early research (Phase 1)Looking for participantsNCT07304128
What this trial is testing

PLB-002 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Primelink BioTherapeitics(ShenZhen) Limited 100
Testing effectiveness (Phase 2)Study completedNCT00003007
What this trial is testing

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Tennessee
Next Page